Developing digital biomarkers with UCB Biopharma
doc.ai, now, a Sharecare company, an enterprise AI platform accelerating digital transformation in healthcare, and UCB, a multinational biopharma company headquartered in Brussels, Belgium, today announced a new collaboration in AI medical research with the launch of a digital health trial for myasthenia gravis, a neuromuscular disease that can lead to impaired speech, blurred vision, difficulty swallowing, and other symptoms.
Introducing AI: the newest member of your healthcare team
We have a perfectly designed $3.9 trillion healthcare system. It’s perfectly designed to deliver more healthcare, not enable better health. But what is it that people really want? Dr. Nirav Shah, Sharecare's Chief Medical Officer, weighs in.
The right tech can add real-world context to clinical trials.
SVP of Clinical Product and Innovation, Dr. Francesca Rinaldo, speaks to Outsourcing Pharma about how Smart Omix can provide researchers with the tools to unlock the potential of decentralized real-world clinical research. Conducting trials in a decentralized manner will no longer be a "nice to have" but a "need to have."